ANDRELL INTERNATIONAL, LLC – Trademark Portfolio
Entity Type: 16
ANDRELL INTERNATIONAL, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include EVITAMINS. The owner is based in UTICA, MI.
6833 AUBURN RD.
UTICA, MI 48317
Showing of trademarks Trademarks
Trademark Classifications
ANDRELL INTERNATIONAL, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ANDRELL INTERNATIONAL, LLC have?
ANDRELL INTERNATIONAL, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.
What trademark classes does ANDRELL INTERNATIONAL, LLC file in?
ANDRELL INTERNATIONAL, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are ANDRELL INTERNATIONAL, LLC's most well-known trademarks?
ANDRELL INTERNATIONAL, LLC's registered trademark portfolio includes well-known marks such as EVITAMINS. These are among 1 currently registered trademark in the portfolio.
What is ANDRELL INTERNATIONAL, LLC's trademark registration success rate?
ANDRELL INTERNATIONAL, LLC has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.